GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spexis AG (XSWX:SPEX) » Definitions » Pre-Tax Income

Spexis AG (XSWX:SPEX) Pre-Tax Income : CHF-19.62 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Spexis AG Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Spexis AG's pretax income for the six months ended in Dec. 2023 was CHF-15.71 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-19.62 Mil. Spexis AG's pretax margin was %.

During the past 11 years, Spexis AG's highest Pretax Margin was -279.02%. The lowest was -646710.00%. And the median was -578.64%.


Spexis AG Pre-Tax Income Historical Data

The historical data trend for Spexis AG's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spexis AG Pre-Tax Income Chart

Spexis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -64.67 -1.85 -11.86 -18.55 -19.62

Spexis AG Semi-Annual Data
Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.85 -9.97 -8.58 -3.91 -15.71

Competitive Comparison of Spexis AG's Pre-Tax Income

For the Biotechnology subindustry, Spexis AG's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spexis AG's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spexis AG's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Spexis AG's Pre-Tax Income falls into.



Spexis AG Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Spexis AG's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-21.305+0+-0.935+0.174+2.447
=-19.62

Spexis AG's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-16.989+0+-0.721+0.129+1.871
=-15.71

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-19.62 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Spexis AG  (XSWX:SPEX) Pre-Tax Income Explanation

Spexis AG's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-15.71/0
=%

During the past 11 years, Spexis AG's highest Pretax Margin was -279.02%. The lowest was -646710.00%. And the median was -578.64%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Spexis AG Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Spexis AG's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Spexis AG (XSWX:SPEX) Business Description

Traded in Other Exchanges
Address
Hegenheimermattweg 125, Allschwil, CHE, CH-4123
Spexis AG is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases. The company's lead product, murepavadin, is in Phase III development against Pseudomonas aeruginosa - recognized as a critical priority 1 pathogen by World Health Organization. It has one operating segment focusing on the research and development and prospective commercialization of respiratory therapeutics addressing high unmet medical needs.

Spexis AG (XSWX:SPEX) Headlines

No Headlines